AIM ImmunoTech Inc Registered Shs Aktie
accesso® Acquires Dexibit®, Establishing the First Cross Platform AI and Analytics Platform for Visitor Attractions
accesso® Acquires Dexibit®, Establishing the First Cross Platform AI and Analytics Platform for Visitor Attractions
The State Fair of Texas Extends Partnership with accesso® Through 2030, Embracing Innovation and Guest Convenience
The State Fair of Texas Extends Partnership with accesso® Through 2030, Embracing Innovation and Guest Convenience
accesso® and Adyen Expand Strategic Partnership to Enhance Platform Payments Capabilities at Global Scale
accesso® and Adyen Expand Strategic Partnership to Enhance Platform Payments Capabilities at Global Scale
accesso® Expands Venue-Controlled Resale Capability
accesso® Expands Venue-Controlled Resale Capability
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
accesso® to Showcase AI-Powered Shopping Preview and New Innovation at IAAPA Orlando 2025
accesso® to Showcase AI-Powered Shopping Preview and New Innovation at IAAPA Orlando 2025